Mollie E Barnard1, Alexander Pyden2, Megan S Rice3, Miguel Linares4, Shelley S Tworoger5, Brooke E Howitt6, Emily E Meserve7, Jonathan L Hecht8. 1. Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, United States of America. Electronic address: mollie.barnard@mail.harvard.edu. 2. Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, United States of America. Electronic address: apyden@bidmc.harvard.edu. 3. Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, Bartlett Ext., 9th Floor 55 Fruit St., Boston, MA 02114, United States of America; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, United States of America. Electronic address: mrice1@mgh.harvard.edu. 4. Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, Bartlett Ext., 9th Floor 55 Fruit St., Boston, MA 02114, United States of America. Electronic address: miguel.linares@ucsf.edu. 5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, United States of America; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, United States of America. Electronic address: Shelley.Tworoger@moffitt.org. 6. Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Lane 235, Stanford, CA 94305-5324, United States of America; Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, United States of America. Electronic address: bhowitt@stanford.edu. 7. Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, United States of America; Department of Anatomic & Clinical Pathology, Maine Medical Center, Tufts University School of Medicine, 22 Bramhall Street, Portland, ME 04102-3175, United States of America. Electronic address: EMeserve@mmc.org. 8. Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, United States of America. Electronic address: jlhecht@bidmc.harvard.edu.
Abstract
BACKGROUND: Grade and histotype of ovarian carcinomas are often used as surrogates of molecular subtypes. We examined factors affecting pathologists' reproducibility in two prospective studies. METHODS: Two pathologists independently reviewed slides from 459 incident ovarian cancers in the Nurses' Health Study (NHS) and NHSII. We described agreement on tumor characteristics using percent agreement and Cohen's standard kappa (κ) coefficients. We used logistic regression, with disagreement as the outcome, to evaluate the contribution of case and tumor characteristics to agreement. RESULTS: Inter-rater agreement was 95% (κ = 0.81) for carcinoma versus borderline, 89% (κ = 0.58) for grade and 85% (κ = 0.71) for histotype. Inter-rater grading disagreement was higher for non-serous histotypes (OR = 4.66, 95% CI 2.09-10.36) and lower for cancers with bizarre atypia (OR = 0.13, 95% CI 0.04-0.38). Agreement with original pathology reports was 94% (κ = 0.73) for carcinoma versus borderline, 78% (κ = 0.60) for histotype, and 79% (κ = 0.24) for grade. Grading disagreement was significantly lower for tumors with 'solid, pseudoendometrioid or transitional' (SET) architecture (OR = 0.08, 95%CI 0.01-0.84). Date of original diagnosis, hospital type, number of slides available for review, tumor stage, and slide quality were not related to agreement. CONCLUSION: Overall, inter-rater agreement for tumor type and grade for archival tissue specimens was good. Agreement between the consensus review and original pathology reports was lower. Factors contributing to grading disagreement included non-serous histotype, absence of bizarre atypia, and absence of SET architecture.
BACKGROUND: Grade and histotype of ovarian carcinomas are often used as surrogates of molecular subtypes. We examined factors affecting pathologists' reproducibility in two prospective studies. METHODS: Two pathologists independently reviewed slides from 459 incident ovarian cancers in the Nurses' Health Study (NHS) and NHSII. We described agreement on tumor characteristics using percent agreement and Cohen's standard kappa (κ) coefficients. We used logistic regression, with disagreement as the outcome, to evaluate the contribution of case and tumor characteristics to agreement. RESULTS: Inter-rater agreement was 95% (κ = 0.81) for carcinoma versus borderline, 89% (κ = 0.58) for grade and 85% (κ = 0.71) for histotype. Inter-rater grading disagreement was higher for non-serous histotypes (OR = 4.66, 95% CI 2.09-10.36) and lower for cancers with bizarre atypia (OR = 0.13, 95% CI 0.04-0.38). Agreement with original pathology reports was 94% (κ = 0.73) for carcinoma versus borderline, 78% (κ = 0.60) for histotype, and 79% (κ = 0.24) for grade. Grading disagreement was significantly lower for tumors with 'solid, pseudoendometrioid or transitional' (SET) architecture (OR = 0.08, 95%CI 0.01-0.84). Date of original diagnosis, hospital type, number of slides available for review, tumor stage, and slide quality were not related to agreement. CONCLUSION: Overall, inter-rater agreement for tumor type and grade for archival tissue specimens was good. Agreement between the consensus review and original pathology reports was lower. Factors contributing to grading disagreement included non-serous histotype, absence of bizarre atypia, and absence of SET architecture.
Authors: Martin Köbel; Steve E Kalloger; Sandra Lee; Máire A Duggan; Linda E Kelemen; Leah Prentice; Kimberly R Kalli; Brooke L Fridley; Daniel W Visscher; Gary L Keeney; Robert A Vierkant; Julie M Cunningham; Christine Chow; Roberta B Ness; Kirsten Moysich; Robert Edwards; Francesmary Modugno; Clareann Bunker; Eva L Wozniak; Elizabeth Benjamin; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; C Blake Gilks; David G Huntsman; Susan J Ramus; Ellen L Goode Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07-23 Impact factor: 4.254
Authors: Brooke E Howitt; Suchanan Hanamornroongruang; Douglas I Lin; James E Conner; Stephanie Schulte; Neil Horowitz; Christopher P Crum; Emily E Meserve Journal: Am J Surg Pathol Date: 2015-03 Impact factor: 6.394
Authors: Robert J Morgan; Deborah K Armstrong; Ronald D Alvarez; Jamie N Bakkum-Gamez; Kian Behbakht; Lee-May Chen; Larry Copeland; Marta Ann Crispens; Maria DeRosa; Oliver Dorigo; David M Gershenson; Heidi J Gray; Ardeshir Hakam; Laura J Havrilesky; Carolyn Johnston; Shashikant Lele; Lainie Martin; Ursula A Matulonis; David M O'Malley; Richard T Penson; Sanja Percac-Lima; Mario Pineda; Steven C Plaxe; Matthew A Powell; Elena Ratner; Steven W Remmenga; Peter G Rose; Paul Sabbatini; Joseph T Santoso; Theresa L Werner; Jennifer Burns; Miranda Hughes Journal: J Natl Compr Canc Netw Date: 2016-09 Impact factor: 11.908
Authors: Boris Winterhoff; Habib Hamidi; Chen Wang; Kimberly R Kalli; Brooke L Fridley; Judy Dering; Hsiao-Wang Chen; William A Cliby; He-Jing Wang; Sean Dowdy; Bobbie S Gostout; Gary L Keeney; Ellen L Goode; Gottfried E Konecny Journal: Gynecol Oncol Date: 2016-04 Impact factor: 5.482
Authors: Robert A Soslow; Guangming Han; Kay J Park; Karuna Garg; Narciso Olvera; David R Spriggs; Noah D Kauff; Douglas A Levine Journal: Mod Pathol Date: 2011-12-23 Impact factor: 7.842
Authors: Rayna K Matsuno; Mark E Sherman; Kala Visvanathan; Marc T Goodman; Brenda Y Hernandez; Charles F Lynch; Olga B Ioffe; David Horio; Charles Platz; Sean F Altekruse; Ruth M Pfeiffer; William F Anderson Journal: Cancer Causes Control Date: 2013-02-03 Impact factor: 2.506
Authors: Laura D Kubzansky; Shelley S Tworoger; Andrea L Roberts; Tianyi Huang; Karestan C Koenen; Yongjoo Kim Journal: Cancer Res Date: 2019-09-05 Impact factor: 12.701
Authors: Andrea L Buras; Cassandra A Hathaway; Tianyi Wang; Mary K Townsend; Shelley S Tworoger Journal: Cancer Med Date: 2021-03-11 Impact factor: 4.452
Authors: Jaclyn C Watkins; Michael J Downing; Marta Crous-Bou; Evan L Busch; Maxine Chen; Immaculata De Vivo; George L Mutter Journal: J Cancer Epidemiol Date: 2021-03-12
Authors: Kun-Hsing Yu; Vincent Hu; Feiran Wang; Ursula A Matulonis; George L Mutter; Jeffrey A Golden; Isaac S Kohane Journal: BMC Med Date: 2020-08-18 Impact factor: 8.775
Authors: Lena Steinkasserer; Delmarko Irmgard; Tatjana Weiss; Walter Dirschlmayer; Michael Mossig; Alain G Zeimet; Christian Marth Journal: Arch Gynecol Obstet Date: 2021-06-14 Impact factor: 2.344